Cite
APA Citation
Roboz, G. J., Montesinos, P., Selleslag, D., Wei, A., Jang, J., Falantes, J., Voso, M. T., Sayar, H., Porkka, K., Marlton, P., Almeida, A., Mohan, S., Ravandi, F., Garcia-Manero, G., Skikne, B., & Kantarjian, H. (2016). design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia. Future oncology, 12, 293–302. http://access.bl.uk/ark:/81055/vdc_100149536155.0x000009